首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Structural characterization of the tumor suppressor p16 an ankyrin-like repeat protein.
【2h】

Structural characterization of the tumor suppressor p16 an ankyrin-like repeat protein.

机译:抑癌蛋白p16(锚蛋白样重复蛋白)的结构特征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The p16 protein has been identified as a tumor suppressor that functions by inhibiting the cyclin-dependent kinases CDK4 and CDK6. Deletions or point mutations in the p16 gene have been found in a number cancers, emphasizing its importance in regulating cell cycle progression. Inhibition by p16 occurs through protein-protein interactions with its targets. This is not surprising, since p16 is thought to contain ankyrin-like repeats, motifs implicated in protein-protein interactions. Our goal was to identify structural characteristics of p16 not only as an important step towards understanding CDK4 inhibition but also to explore the role of ankyrin repeats in the p16 structure, as no detailed structure of any protein containing these motifs has been reported. We have expressed, refolded, and purified p16 from E. coli and have shown it to be functionally active by specific binding to CDK4. Analytical ultracentrifugation has shown that p16 weakly self-associates to form dimers with a Kd = 270 microM. The CD spectrum indicates that the protein is composed of 33% alpha-helix, 22% beta-sheet, 19% beta-turn, and 27% other (which includes aromatic and random coil contributions). Further CD experiments suggest that p16 exhibits low structural stability with a delta G of -2.3 kcal/mol. This weak stability is a consequence of a highly dynamic structure as measured by ANS-binding, NMR hydrogen-deuterium exchange, and fluorescence. It is possible that a well-defined tertiary structure is imparted upon the binding of p16 to CDK4.
机译:p16蛋白已被鉴定为通过抑制细胞周期蛋白依赖性激酶CDK4和CDK6发挥功能的肿瘤抑制因子。已在许多癌症中发现了p16基因的缺失或点突变,强调了其在调节细胞周期进程中的重要性。 p16的抑制作用是通过蛋白质与蛋白质与其靶标的相互作用而发生的。这并不奇怪,因为人们认为p16含有锚蛋白样重复序列,这是与蛋白质-蛋白质相互作用有关的基序。我们的目标是鉴定p16的结构特征,这不仅是理解CDK4抑制的重要步骤,而且还探索了锚蛋白重复序列​​在p16结构中的作用,因为尚未报道任何包含这些基序的蛋白质的详细结构。我们已经从大肠杆菌表达,重折叠和纯化了p16,并已表明它通过与CDK4特异性结合而具有功能活性。分析超离心表明,p16弱自缔合形成Kd = 270 microM的二聚体。 CD谱表明该蛋白质由33%的α-螺旋,22%的β-折叠,19%的β-转角和27%的其他(包括芳香族和无规卷曲贡献)组成。进一步的CD实验表明,p16的结构稳定性低,δG为-2.3 kcal / mol。这种弱的稳定性是通过ANS结合,NMR氢-氘交换和荧光测量得到的高度动态结构的结果。当p16与CDK4结合时,可能会赋予明确的三级结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号